Cytokinetics Announced The Primary Results From ACACIA-HCM (Assessment Comparing Aficamten To Placebo On Cardiac Endpoints In Adults With Non-obstructive HCM), The Pivotal Phase 3 Clinical Trial Of Aficamten In Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

뉴스 본문을 불러오고 있어요.

Cytokinetics Announced The Primary Results From ACACIA-HCM (Assessment Comparing Aficamten To Placebo On Cardiac Endpoints In Adults With Non-obstructive HCM), The Pivotal Phase 3 Clinical Trial Of Aficamten In Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy | 웨이프 WAPE

Cytokinetics Announced The Primary Results From ACACIA-HCM (Assessment Comparing Aficamten To Placebo On Cardiac Endpoints In Adults With Non-obstructive HCM), The Pivotal Phase 3 Clinical Trial Of Aficamten In Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

기사 요약

관련 종목

댓글 —